These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37246841)

  • 21. Protocolised reduction of non-resuscitation fluids versus usual care in patients with septic shock (REDUSE): a protocol for a multicentre feasibility trial.
    Lindén A; Fisher J; Lilja G; Olsen MH; Sjövall F; Jungner M; Spångfors M; Samuelsson L; Oras J; Linder A; Unden J; Kander T; Lipcsey M; Nielsen N; Jakobsen JC; Bentzer P
    BMJ Open; 2023 Feb; 13(2):e065392. PubMed ID: 36854601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic model of albumin infusion in septic shock: The EMAISS study.
    Guidet B; Ghout I; Ropers J; Aegerter P
    Acta Anaesthesiol Scand; 2020 Jul; 64(6):781-788. PubMed ID: 32037505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.
    Self WH; Semler MW; Bellomo R; Brown SM; deBoisblanc BP; Exline MC; Ginde AA; Grissom CK; Janz DR; Jones AE; Liu KD; Macdonald SPJ; Miller CD; Park PK; Reineck LA; Rice TW; Steingrub JS; Talmor D; Yealy DM; Douglas IS; Shapiro NI;
    Ann Emerg Med; 2018 Oct; 72(4):457-466. PubMed ID: 29753517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study.
    Corl KA; Prodromou M; Merchant RC; Gareen I; Marks S; Banerjee D; Amass T; Abbasi A; Delcompare C; Palmisciano A; Aliotta J; Jay G; Levy MM
    Crit Care Med; 2019 Jul; 47(7):951-959. PubMed ID: 30985449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Initial Fluid Choice and Subsequent In-hospital Mortality during the Resuscitation of Adults with Septic Shock.
    Raghunathan K; Bonavia A; Nathanson BH; Beadles CA; Shaw AD; Brookhart MA; Miller TE; Lindenauer PK
    Anesthesiology; 2015 Dec; 123(6):1385-93. PubMed ID: 26414499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
    Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb SA; Beale RJ; Vincent JL; Moreno R;
    Crit Care Med; 2013 Feb; 41(2):580-637. PubMed ID: 23353941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trial.
    Cortegiani A; Grasselli G; Meessen J; Moscarelli A; Ippolito M; Turvani F; Bonenti CM; Romagnoli S; Volta CA; Bellani G; Giarratano A; Latini R; Pesenti A; Caironi P
    J Crit Care; 2021 Jun; 63():83-91. PubMed ID: 33636427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dosage of dextran 70 is associated with severe bleeding in patients admitted to the intensive care unit for septic shock.
    Hvidt LN; Perner A
    Dan Med J; 2012 Nov; 59(11):A4531. PubMed ID: 23171749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Septic shock-3 vs 2: an analysis of the ALBIOS study.
    Vasques F; Duscio E; Romitti F; Pasticci I; Caironi P; Meessen J; Latini R; Cressoni M; Camporota L; Pesenti A; Fumagalli R; Quintel M; Gattinoni L
    Crit Care; 2018 Sep; 22(1):237. PubMed ID: 30261898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PRECISE RCT: evolution of an early septic shock fluid resuscitation trial.
    McIntyre L; Fergusson DA; Rowe B; Cook DJ; Arabi Y; Bagshaw SM; Emond M; Finfer S; Fox-Robichaud A; Gray A; Green R; Hebert P; Lang E; Marshall J; Stiell I; Tinmouth A; Pagliarello J; Turgeon A; Walsh T; Worster A; Zarychanski R;
    Transfus Med Rev; 2012 Oct; 26(4):333-41. PubMed ID: 22222146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.
    Unger M; Morelli A; Singer M; Radermacher P; Rehberg S; Trimmel H; Joannidis M; Heinz G; Cerny V; Dostál P; Siebers C; Guarracino F; Pratesi F; Biancofiore G; Girardis M; Kadlecova P; Bouvet O; Zörer M; Grohmann-Izay B; Krejcy K; Klade C; Krumpl G
    Trials; 2018 Nov; 19(1):637. PubMed ID: 30454042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Hyperoncotic Albumin on Duration of Vasopressor Support in Septic Shock: A Propensity Score-Matched Analysis.
    Flannery AH; Owen GD; Coz A; Thompson Bastin ML; Patel K
    Ann Pharmacother; 2021 May; 55(5):584-591. PubMed ID: 33016080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetate Ringer's solution versus 0.9% saline for septic patients: study protocol for a multi-center parallel controlled trial.
    Liu F; Zhang J; Zhu Y; Su L; Li Y; He L; Yu L; Peng Z
    Trials; 2021 Jan; 22(1):89. PubMed ID: 33494795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indications for fluid resuscitation in patients with septic shock: Post-hoc analyses of the CLASSIC trial.
    Bjerregaard MR; Hjortrup PB; Perner A
    Acta Anaesthesiol Scand; 2019 Mar; 63(3):337-343. PubMed ID: 30318584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial.
    Hwang SY; Park JE; Jo IJ; Kim S; Chung SP; Kong T; Shin J; Lee HJ; You KM; Jo YH; Kim D; Suh GJ; Kim T; Kim WY; Kim YJ; Ryoo SM; Choi SH; Shin TG;
    Trials; 2019 Jul; 20(1):420. PubMed ID: 31296251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fluid restriction on measures of circulatory efficacy in adults with septic shock.
    Hjortrup PB; Haase N; Wetterslev J; Lange T; Bundgaard H; Rasmussen BS; Dey N; Wilkman E; Christensen L; Lodahl D; Bestle M; Perner A
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):390-398. PubMed ID: 28150304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database.
    Marik PE; Linde-Zwirble WT; Bittner EA; Sahatjian J; Hansell D
    Intensive Care Med; 2017 May; 43(5):625-632. PubMed ID: 28130687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.